Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Access Microbiology

Plasma metagenomic cell-free DNA sequencing identifies clinically unsuspected cases of Toxoplasma gondii infection in immunocompromised patients: a single-centre experience

6 affiliations
  1. 1University of Minnesota Medical School, Minneapolis, USA
  2. 2Division of Pediatric Infectious Diseases, University of Minnesota Medical School, Minneapolis, USA
  3. 3Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, USA
  4. 4Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, USA
  5. 5Division of Stem Cell Transplantation and Children’s Research Center and Pediatric Hematology and Oncology University Children’s Hospital Zurich, University of Zürich, Zürich, Switzerland
  6. 6Division of Pediatric Hematology and Oncology, Department of Pediatrics, Kantonsspital Aarau, Aarau, Switzerland

Abstract

Toxoplasmosis can be challenging to diagnose, particularly in immunocompromised patients with nonspecific clinical presentations. We present a retrospective, single-centre case series of eight Toxoplasma gondii infections identified by plasma metagenomic cell-free DNA (cfDNA) sequencing in allogeneic haematopoietic stem cell transplant recipients. Nested within a larger cohort evaluating cfDNA utilization, this case series highlights a positive clinical impact of cfDNA testing in 5 out of 8 (62.5%) patients, including earlier diagnosis and changes in clinical management. These findings illustrate the potential utility of plasma cfDNA sequencing as a complement to conventional diagnostics across diverse clinical presentations of toxoplasmosis.

Related

  1. Analysis of structural modifications and metagenomic sequencing during the ensiling of Caragana korshinskii provides insights into how extrusion pretreatment promotes lignocellulose degradation
    Baochao Bai, Gentu Ge, Rui Qiu +7
    Communications BiologyPeer-reviewedCC BY 4.0General biologyNatureCrossref
  2. Benchmarking Microbiome Methods for Improved Metagenomic Sequencing of Lower Respiratory Tract Samples
    J. T. Sumner, E. M. Hartmann
    bioRxivPreprintCC BYFull textMicrobiologybioRxiv
  3. Cerebrospinal fluid metagenomic next-generation sequencing for culture-negative anaerobic central nervous system infection involving Prevotella oris: attribution challenges in low-biomass specimens
    Yan Li, Minghua Fan, Yuyuan Hu +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyPMCCrossrefEurope PMC
  4. Geomosaic: a flexible bioinformatics platform integrating complementary metagenomic analyses from sequencing reads to genomes
    D. Corso, E. Taccaliti, B. Barosa +1
    bioRxivPreprintCC BYFull textBioinformatics & computational biologybioRxiv
  5. Metagenomic next-generation sequencing of aqueous humor guides targeted therapy for Staphylococcus epidermidis endophthalmitis in chronic ocular graft-versus-host disease: a case report
    Jingjing Wang, Junyu Hu, Xing Liang +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCPMCEurope PMC
BibTeX
@article{goren2026plasma,
  title = {{Plasma metagenomic cell-free DNA sequencing identifies clinically unsuspected cases of Toxoplasma gondii infection in immunocompromised patients: a single-centre experience}},
  author = {Lea R. Goren and Alice C. Lehman and Daniel Drozdov and Beth Kristine Thielen},
  journal = {Access Microbiology},
  year = {2026},
  month = nov,
  doi = {10.1099/acmi.0.001068.v4},
  url = {https://doi.org/10.1099/acmi.0.001068.v4},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Plasma metagenomic cell-free DNA sequencing identifies clinically unsuspected cases of Toxoplasma gondii infection in immunocompromised patients: a single-centre experience
AU  - Lea R. Goren
AU  - Alice C. Lehman
AU  - Daniel Drozdov
AU  - Beth Kristine Thielen
PY  - 2026
DA  - 2026/11/12
JO  - Access Microbiology
DO  - 10.1099/acmi.0.001068.v4
UR  - https://doi.org/10.1099/acmi.0.001068.v4
AB  - Toxoplasmosis can be challenging to diagnose, particularly in immunocompromised patients with nonspecific clinical presentations. We present a retrospective, single-centre case series of eight Toxoplasma gondii infections identified by plasma metagenomic cell-free DNA (cfDNA) sequencing in allogeneic haematopoietic stem cell transplant recipients. Nested within a larger cohort evaluating cfDNA utilization, this case series highlights a positive clinical impact of cfDNA testing in 5 out of 8 (62.5%) patients, including earlier diagnosis and changes in clinical management. These findings illustrate the potential utility of plasma cfDNA sequencing as a complement to conventional diagnostics across diverse clinical presentations of toxoplasmosis.
SN  - 2516-8290
ER  -